✦ LIBER ✦

Variants in the APOA5 gene region and the response to combination therapy with statins and fenofibric acid in a randomized clinical trial of individuals with mixed dyslipidemia

✍ Scribed by Ariel Brautbar; Daniel Covarrubias; John Belmont; Fremiet Lara-Garduno; Salim S. Virani; Peter H. Jones; Suzanne M. Leal; Christie M. Ballantyne

Book ID: 118423795
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 125 KB
Volume: 219
Category: Article
ISSN: 0021-9150
DOI: 10.1016/j.atherosclerosis.2011.08.015

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rare LPL gene variants attenuate triglyc

Rare LPL gene variants attenuate triglyceride reduction and HDL cholesterol increase in response to fenofibric acid therapy in individuals with mixed dyslipidemia

✍ Gao, Feng; Ballantyne, Christie; Ma, Li; Virani, Salim S.; Keinan, Alon; Brautba 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 210 KB

Long-term safety and efficacy of fenofib

Long-term safety and efficacy of fenofibric acid in combination with statin therapy for the treatment of patients with mixed dyslipidemia

✍ Harold E. Bays; Peter H. Jones; Syed M. Mohiuddin; Maureen T. Kelly; Hsiaoming S 📂 Article 📅 2008 🏛 Elsevier 🌐 English ⚖ 492 KB

PCV2 PREDICTED OPTIMAL LIPID VALUE ATTAI

PCV2 PREDICTED OPTIMAL LIPID VALUE ATTAINMENT RATES WITH THE CO-ADMINISTRATION OF FENOFIBRIC ACID AND A STATIN COMPARED TO STATIN MONOTHERAPY IN HISPANIC PATIENTS WITH MIXED DYSLIPIDEMIA

✍ Webb, SF; Simko, RJ 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

Randomized trial of high-dose interferon

Randomized trial of high-dose interferon-α-2b combined with ribavirin in patients with chronic hepatitis C: Correlation between amino acid substitutions in the core/NS5A region and virological response to interferon therapy

✍ Nami Mori; Michio Imamura; Yoshiiku Kawakami; Hiromi Saneto; Tomokazu Kawaoka; S 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 275 KB 👁 1 views

## Abstract The aim of this study was to compare the efficacy of high‐dose interferon (IFN)‐α‐2b with standard dose of IFN‐α‐2b in combination with ribavirin (RBV) for patients with chronic hepatitis C virus (HCV) infection, and to investigate the predictive factors associated with virological resp

A Randomized Controlled Trial to Investi

A Randomized Controlled Trial to Investigate the Feasibility and Clinical Efficacy of Whole Body Vibration Therapy in Modifying Bone Metabolism and Neuromotor Performance in Individuals with Chronic Stroke

✍ R.W.K. Lau; S.P. Yip; M.Y.C. Pang 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 34 KB

Rationale and design of the avoiding car

Rationale and design of the avoiding cardiovascular events through combination therapy in patients living with systolic hypertension (ACCOMPLISH) trial: The first randomized controlled trial to compare the clinical outcome effects of first-line combination therapies in hypertension

✍ Kenneth A. Jamerson; George L. Bakris; Chuan-Chuan Wun; Björn Dahlöf; Martin Lef 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 147 KB